Geneos Wealth Management’s Broadridge BR Stock Holding History

Geneos Wealth Management’s Portfolio BR Stock Details BR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Sell	646 -4,161	-87%	-$790K	﹤0.01%	1154
2025 Q4	$1.07M	Buy	4,807 +528	+12%	+$120K	0.03%	487
2025 Q3	$1.02M	Buy	4,279 +141	+3%	+$35.1K	0.03%	488
2025 Q2	$1.01M	Sell	4,138 -991	-19%	-$236K	0.02%	532
2025 Q1	$1.24M	Buy	5,129 +3,553	+225%	+$836K	0.02%	607
2024 Q4	$356K	Buy	1,576 +65	+4%	+$14.6K	0.01%	666
2024 Q3	$325K	Buy	1,511 +1,320	+691%	+$276K	0.01%	648
2024 Q2	$37.5K	Sell	191 -102	-35%	-$20.2K	﹤0.01%	1160
2024 Q1	$59.9K	Sell	293 -25,058	-99%	-$5.05M	﹤0.01%	1009
2023 Q4	$5.22M	Sell	25,351 -10,698	-30%	-$1.97M	0.26%	96
2023 Q3	$6.45M	Buy	36,049 +17	+0%	+$3.01K	0.33%	68
2023 Q2	$5.97M	Buy	36,032 +6,089	+20%	+$921K	0.31%	74
2023 Q1	$4.39M	Buy	29,943 +29,756	+15,912%	+$4.26M	0.27%	95
2022 Q4	$25.1K	Hold	187	–	–	﹤0.01%	1262
2022 Q3	$26K	Sell	187 -141	-43%	-$22.9K	﹤0.01%	1240
2022 Q2	$48K	Buy	328 +1	+0.3%	+$145	﹤0.01%	1296
2022 Q1	$50K	Sell	327 -12	-4%	-$1.84K	﹤0.01%	1382
2021 Q4	$62K	Buy	339 +13	+4%	+$2.29K	﹤0.01%	1377
2021 Q3	$54K	Hold	326	–	–	﹤0.01%	1448
2021 Q2	$53K	Sell	326 -116	-26%	-$18.5K	﹤0.01%	1450
2021 Q1	$70K	Buy	442 +1	+0.2%	+$148	﹤0.01%	1452
2020 Q4	$65K	Sell	441 -8	-2%	-$1.16K	﹤0.01%	1323
2020 Q3	$58K	Hold	449	–	–	﹤0.01%	1182
2020 Q2	$56K	Buy	449 +88	+24%	+$10.2K	﹤0.01%	1165
2020 Q1	$33K	Buy	361 +25	+7%	+$2.85K	﹤0.01%	1293
2019 Q4	$41K	Buy	336 +1	+0.3%	+$122	﹤0.01%	1350
2019 Q3	$41K	Hold	335	–	–	﹤0.01%	1282
2019 Q2	$42K	Buy	335 +1	+0.3%	+$120	﹤0.01%	1278
2019 Q1	$34K	Hold	334	–	–	﹤0.01%	1329
2018 Q4	$31K	Buy	334 +1	+0.3%	+$108	﹤0.01%	1311
2018 Q3	$44K	Hold	333	–	–	﹤0.01%	1226
2018 Q2	$38K	Hold	333	–	–	﹤0.01%	1169
2018 Q1	$36K	Buy	333 +1	+0.3%	+$99	﹤0.01%	1146
2017 Q4	$30K	Sell	332 -55	-14%	-$4.8K	﹤0.01%	1228
2017 Q3	$31K	Buy	387 +1	+0.3%	+$77	﹤0.01%	1151
2017 Q2	$29K	Hold	386	–	–	﹤0.01%	1128
2017 Q1	$26K	Sell	386 -16	-4%	-$1.08K	﹤0.01%	1141
2016 Q4	$26K	Hold	402	–	–	﹤0.01%	1074
2016 Q3	$27K	Buy	402 +17	+4%	+$1.16K	﹤0.01%	1020
2016 Q2	$25K	Sell	385 -189	-33%	-$11.7K	﹤0.01%	1034
2016 Q1	$34K	Buy	+574	New	+$31.3K	0.01%	918

Other funds holding BR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's BR Position: Q1 2026 in Review

Geneos Wealth Management reduced its Broadridge (BR) stake by 87% in Q1 2026, selling an estimated $790K and leaving 646 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Geneos Wealth Management first reported a position in BR in Q1 2016 and has held it in 41 quarters since. The position peaked at $6.45M in Q3 2023. 1,054 funds tracked by Wall St. Rank hold BR as of Q1 2026.

Geneos Wealth Management held 646 shares of Broadridge worth $105K as of Q1 2026.
Geneos Wealth Management sold 4,161 Broadridge shares in Q1 2026, an estimated $790K.
Broadridge made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1154 holding.
Geneos Wealth Management first reported a position in Broadridge in Q1 2016 and has held it in 41 quarters since.
Geneos Wealth Management's Broadridge position peaked at $6.45M in Q3 2023.
1,054 funds tracked by Wall St. Rank held Broadridge as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.